Timeline Nutrition
Timeline is eyeing category expansion.
The latest: The Swiss longevity supplement brand raised $66M in an oversubscribed Series D round co-led by Nestlé Health Science and L’Oréal’s VC arm BOLD.
The company’s clinical Mitopure technology boosts cellular health, supporting muscle strength, cognition, immunity, skin, and more for healthy aging.
Aided by the global CPG giants, Timeline will use the funds to extend its proprietary anti-aging tech across new products and sectors, including food and beauty.
Why it matters: From an aesthetic, physiologic, and economic standpoint, anti-aging offers massive returns — delaying age-related deterioration by just one year would save the US $38T.
A new but rapidly expanding science, supplements in this territory don’t require a prescription, allowing biotech companies to scale healthspan-extending ingestibles D2C.
- David Sinclair’s Tally Health, which combines epigenetic tests with personalized lifestyle recommendations and supplements, secured $10M last April.
- Leveraging NAD+, Elysium Health offers a range of cellular, immune, brain, and metabolic aging solutions.
- Backed by Andrew Huberman, Stacy Simms, Kelly Starrett, and more, Momentous targets athletes and high performers.
Punchline: Pouring resources into research centers, studies, and product development, consumer-facing biotech brands are catapulting the longevity economy ahead.
